Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
3.02
1.39
46.03%
Share Warrants & Outstandings
Total Reserve
192.63
194.15
-1.52
-0.78%
Shareholder's Funds
197.04
197.18
-0.14
-0.07%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
17.31
-17.31
-100.00%
Secured Loans
0.00
17.31
-17.31
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-1.42
13.59
-15.01
-110.45%
Other Long Term Liabilities
4.85
1.74
3.11
178.74%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
4.20
-4.20
-100.00%
Total Non-Current Liabilities
3.43
36.84
-33.41
-90.69%
Current Liabilities
Trade Payables
8.10
45.98
-37.88
-82.38%
Other Current Liabilities
8.45
14.85
-6.40
-43.10%
Short Term Borrowings
0.00
61.86
-61.86
-100.00%
Short Term Provisions
6.59
1.59
5.00
314.47%
Total Current Liabilities
23.15
124.30
-101.15
-81.38%
Total Liabilities
223.61
358.31
-134.70
-37.59%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
38.39
210.61
-172.22
-81.77%
Less: Accumulated Depreciation
26.85
62.15
-35.30
-56.80%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.55
148.46
-136.91
-92.22%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
46.12
0.40
45.72
11,430.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
27.02
23.23
3.79
16.32%
Long Term Loans & Advances
3.64
6.66
-3.02
-45.35%
Other Non Current Assets
32.28
0.00
32.28
0.00%
Total Non-Current Assets
128.52
180.52
-52.00
-28.81%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.63
60.58
-46.95
-77.50%
Sundry Debtors
24.36
64.53
-40.17
-62.25%
Cash and Bank
53.11
1.41
51.70
3,666.67%
Other Current Assets
1.97
7.20
-5.23
-72.64%
Short Term Loans and Advances
2.01
44.07
-42.06
-95.44%
Total Current Assets
95.09
177.79
-82.70
-46.52%
Net Current Assets (Including Current Investments)
71.94
53.49
18.45
34.49%
Total Current Assets Excluding Current Investments
95.09
177.79
-82.70
-46.52%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
223.61
358.31
-134.70
-37.59%
Contingent Liabilities
17.20
23.58
-6.38
-27.06%
Total Debt
0.00
79.17
-79.17
-100.00%
Book Value per share (adjusted)
446.47
652.19
-205.72
-31.54%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.85 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Annual - Fixed Assets
Fixed Assets 57.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Annual - Investments
Investments 27.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Annual - Current Assets
Current Assets 95.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
